Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1998 Nov;90(11):665–674.

Neuropsychological functioning in HIV-positive African-American women with a history of drug use.

K I Mason 1, A Campbell 1, P Hawkins 1, S Madhere 1, K Johnson 1, R Takushi-Chinen 1
PMCID: PMC2608385  PMID: 9828581

Abstract

This preliminary investigation examined neuropsychological performance in a sample of human immunodeficiency virus (HIV)-positive and HIV-negative African-American women with a history of drug use. The study population was comprised of 10 HIV-negative, 9 asymptomatic HIV-positive, 13 symptomatic HIV-positive, and 10 acquired immunodeficiency virus (AIDS) patients. A neuropsychological battery designed to assess attention, psychomotor processing, verbal memory, and visual memory was administered to participants. No evidence of HIV-related cognitive impairment was found in patients in the early stages of HIV infection. Multivariate analyses of variance revealed significant deficits in psychomotor processing and verbal recall in persons with AIDS. These individuals showed greater difficulty in tasks requiring maintained attention and performed poorly on measures of immediate and delayed verbal recall. In contrast, HIV status was not related to visual memory, verbal recognition, or the number of errors made during a verbal recall task. The pattern of cognitive deficits observed in persons with AIDS resembles that commonly associated with subcortical pathology. The cognitive deficits observed were not related to depression or recentness of drug use.

Full text

PDF
665

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldeweg T., Catalan J., Lovett E., Gruzelier J., Riccio M., Hawkins D. Long-term zidovudine reduces neurocognitive deficits in HIV-1 infection. AIDS. 1995 Jun;9(6):589–596. doi: 10.1097/00002030-199506000-00010. [DOI] [PubMed] [Google Scholar]
  2. Becker J. T., Caldararo R., Lopez O. L., Dew M. A., Dorst S. K., Banks G. Qualitative features of the memory deficit associated with HIV infection and AIDS: cross-validation of a discriminant function classification scheme. J Clin Exp Neuropsychol. 1995 Feb;17(1):134–142. doi: 10.1080/13803399508406588. [DOI] [PubMed] [Google Scholar]
  3. Becker J. T., Sanchez J., Dew M. A., Lopez O. L., Dorst S. K., Banks G. Neuropsychological abnormalities among HIV-infected individuals in a community-based sample. Neuropsychology. 1997 Oct;11(4):592–601. doi: 10.1037//0894-4105.11.4.592. [DOI] [PubMed] [Google Scholar]
  4. Bono G., Mauri M., Sinforiani E., Barbarini G., Minoli L., Fea M. Longitudinal neuropsychological evaluation of HIV-infected intravenous drug users. Addiction. 1996 Feb;91(2):263–268. doi: 10.1046/j.1360-0443.1996.9122638.x. [DOI] [PubMed] [Google Scholar]
  5. Bornstein R. A., Nasrallah H. A., Para M. F., Whitacre C. C., Fass R. J. Duration of illness and neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci. 1994 Spring;6(2):160–164. doi: 10.1176/jnp.6.2.160. [DOI] [PubMed] [Google Scholar]
  6. Bornstein R. A., Pace P., Rosenberger P., Nasrallah H. A., Para M. F., Whitacre C. C., Fass R. J. Depression and neuropsychological performance in asymptomatic HIV infection. Am J Psychiatry. 1993 Jun;150(6):922–927. doi: 10.1176/ajp.150.6.922. [DOI] [PubMed] [Google Scholar]
  7. Brouwers P., Hendricks M., Lietzau J. A., Pluda J. M., Mitsuya H., Broder S., Yarchoan R. Effect of combination therapy with zidovudine and didanosine on neuropsychological functioning in patients with symptomatic HIV disease: a comparison of simultaneous and alternating regimens. AIDS. 1997 Jan;11(1):59–66. doi: 10.1097/00002030-199701000-00009. [DOI] [PubMed] [Google Scholar]
  8. Butters N., Grant I., Haxby J., Judd L. L., Martin A., McClelland J., Pequegnat W., Schacter D., Stover E. Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches. J Clin Exp Neuropsychol. 1990 Dec;12(6):963–978. doi: 10.1080/01688639008401035. [DOI] [PubMed] [Google Scholar]
  9. Butters N., Tarlow S., Cermak L. S., Sax D. A comparison of the information processing deficits of patients with Huntington's chorea and Korsakoff's syndrome. Cortex. 1976 Jun;12(2):134–144. doi: 10.1016/s0010-9452(76)80017-2. [DOI] [PubMed] [Google Scholar]
  10. Claypoole K. H., Townes B. D., Collier A. C., Marra C., Longstreth W. T., Jr, Cohen W., Martin D., Coombs R. W., Goldstein D., Sanchez P. Cognitive risk factors and neuropsychological performance in HIV infection. Int J Neurosci. 1993 May;70(1-2):13–27. doi: 10.3109/00207459309000557. [DOI] [PubMed] [Google Scholar]
  11. Drebing C. E., Van Gorp W. G., Hinkin C., Miller E. N., Satz P., Kim D. S., Holston S., D'Elia L. F. Confounding factors in the measurement of depression in HIV. J Pers Assess. 1994 Feb;62(1):68–83. doi: 10.1207/s15327752jpa6201_7. [DOI] [PubMed] [Google Scholar]
  12. Egan V. Neuropsychological aspects of HIV infection. AIDS Care. 1992;4(1):3–10. doi: 10.1080/09540129208251615. [DOI] [PubMed] [Google Scholar]
  13. Grant I., Heaton R. K. Human immunodeficiency virus-type 1 (HIV-1) and the brain. J Consult Clin Psychol. 1990 Feb;58(1):22–30. doi: 10.1037//0022-006x.58.1.22. [DOI] [PubMed] [Google Scholar]
  14. Grassi M. P., Clerici F., Perin C., Zocchetti C., Borella M., Cargnel A., Mangoni A. HIV infection and drug use: influence on cognitive function. AIDS. 1995 Feb;9(2):165–170. [PubMed] [Google Scholar]
  15. Grassi M. P., Perin C., Clerici F., Zocchetti C., Borella M., Cargnel A., Mangoni A. Effects of HIV seropositivity and drug abuse on cognitive function. Eur Neurol. 1997;37(1):48–52. doi: 10.1159/000117405. [DOI] [PubMed] [Google Scholar]
  16. Handelsman L., Aronson M., Maurer G., Wiener J., Jacobson J., Bernstein D., Ness R., Herman S., Losonczy M., Song I. S. Neuropsychological and neurological manifestations of HIV-1 dementia in drug users. J Neuropsychiatry Clin Neurosci. 1992 Winter;4(1):21–28. doi: 10.1176/jnp.4.1.21. [DOI] [PubMed] [Google Scholar]
  17. Kalichman S. C., Sikkema K. J., Somlai A. Assessing persons with human immunodeficiency virus (HIV) infection using the Beck Depression Inventory: disease processes and other potential confounds. J Pers Assess. 1995 Feb;64(1):86–100. doi: 10.1207/s15327752jpa6401_5. [DOI] [PubMed] [Google Scholar]
  18. Kelly P. J., Holman S. The new face of AIDS. Am J Nurs. 1993 Mar;93(3):26–34. [PubMed] [Google Scholar]
  19. Massman P. J., Delis D. C., Butters N., Dupont R. M., Gillin J. C. The subcortical dysfunction hypothesis of memory deficits in depression: neuropsychological validation in a subgroup of patients. J Clin Exp Neuropsychol. 1992 Sep;14(5):687–706. doi: 10.1080/01688639208402856. [DOI] [PubMed] [Google Scholar]
  20. Peavy G., Jacobs D., Salmon D. P., Butters N., Delis D. C., Taylor M., Massman P., Stout J. C., Heindel W. C., Kirson D. Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group. J Clin Exp Neuropsychol. 1994 Aug;16(4):508–523. doi: 10.1080/01688639408402662. [DOI] [PubMed] [Google Scholar]
  21. Poutiainen E. Cognitive deficits and emotional disorders in HIV-1 infected individuals. Acta Psychiatr Scand. 1995 Dec;92(6):429–435. doi: 10.1111/j.1600-0447.1995.tb09608.x. [DOI] [PubMed] [Google Scholar]
  22. Reed B. G. Developing women-sensitive drug dependence treatment services: why so difficult? J Psychoactive Drugs. 1987 Apr-Jun;19(2):151–164. doi: 10.1080/02791072.1987.10472399. [DOI] [PubMed] [Google Scholar]
  23. Royal W., 3rd, Updike M., Selnes O. A., Proctor T. V., Nance-Sproson L., Solomon L., Vlahov D., Cornblath D. R., McArthur J. C. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology. 1991 Dec;41(12):1905–1910. doi: 10.1212/wnl.41.12.1905. [DOI] [PubMed] [Google Scholar]
  24. Schmitt F. A., Bigley J. W., McKinnis R., Logue P. E., Evans R. W., Drucker J. L. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med. 1988 Dec 15;319(24):1573–1578. doi: 10.1056/NEJM198812153192404. [DOI] [PubMed] [Google Scholar]
  25. Selnes O. A., Galai N., Bacellar H., Miller E. N., Becker J. T., Wesch J., Van Gorp W., McArthur J. C. Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study. Neurology. 1995 Feb;45(2):267–275. doi: 10.1212/wnl.45.2.267. [DOI] [PubMed] [Google Scholar]
  26. Selnes O. A., Galai N., McArthur J. C., Cohn S., Royal W., 3rd, Esposito D., Vlahov D. HIV infection and cognition in intravenous drug users: long-term follow-up. Neurology. 1997 Jan;48(1):223–230. doi: 10.1212/wnl.48.1.223. [DOI] [PubMed] [Google Scholar]
  27. Selnes O. A., McArthur J. C., Royal W., 3rd, Updike M. L., Nance-Sproson T., Concha M., Gordon B., Solomon L., Vlahov D. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology. 1992 Oct;42(10):1924–1930. doi: 10.1212/wnl.42.10.1924. [DOI] [PubMed] [Google Scholar]
  28. Silberstein C. H., O'Dowd M. A., Chartock P., Schoenbaum E. E., Friedland G., Hartel D., McKegney F. P. A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients. Gen Hosp Psychiatry. 1993 Nov;15(6):351–359. doi: 10.1016/0163-8343(93)90001-5. [DOI] [PubMed] [Google Scholar]
  29. Wellman M. C. Neuropsychological impairment among intravenous drug users in pre-AIDS stages of HIV infection. Int J Neurosci. 1992 May-Jun;64(1-4):183–194. doi: 10.3109/00207459209000544. [DOI] [PubMed] [Google Scholar]
  30. White D. A., Heaton R. K., Monsch A. U. Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc. 1995 May;1(3):304–315. doi: 10.1017/s1355617700000308. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES